New York State Common Retirement Fund Purchases 44,709 Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN)

New York State Common Retirement Fund lifted its position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 16.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 323,257 shares of the company's stock after purchasing an additional 44,709 shares during the period. New York State Common Retirement Fund owned about 0.51% of Guardian Pharmacy Services worth $6,872,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in GRDN. Brown Advisory Inc. bought a new stake in Guardian Pharmacy Services during the fourth quarter valued at $32,294,000. Geode Capital Management LLC bought a new position in shares of Guardian Pharmacy Services during the fourth quarter worth about $4,073,000. Renaissance Technologies LLC bought a new position in shares of Guardian Pharmacy Services during the fourth quarter worth about $2,859,000. Northern Trust Corp acquired a new stake in Guardian Pharmacy Services in the fourth quarter worth about $1,479,000. Finally, Peregrine Capital Management LLC lifted its holdings in Guardian Pharmacy Services by 56.1% in the first quarter. Peregrine Capital Management LLC now owns 176,539 shares of the company's stock worth $3,753,000 after purchasing an additional 63,464 shares during the period.

Guardian Pharmacy Services Stock Performance

Shares of NYSE:GRDN traded down $0.60 during midday trading on Tuesday, reaching $20.30. The company's stock had a trading volume of 126,956 shares, compared to its average volume of 182,791. The business's fifty day simple moving average is $21.48 and its 200-day simple moving average is $21.45. Guardian Pharmacy Services, Inc. has a fifty-two week low of $14.16 and a fifty-two week high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $0.21 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The business had revenue of $329.31 million during the quarter, compared to analysts' expectations of $321.21 million. On average, equities research analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Insiders Place Their Bets

In other Guardian Pharmacy Services news, insider Fred Burke sold 138,705 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $20.16, for a total transaction of $2,796,292.80. Following the transaction, the insider owned 413,019 shares of the company's stock, valued at $8,326,463.04. The trade was a 25.14% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director John Ackerman sold 201,303 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $20.16, for a total value of $4,058,268.48. Following the transaction, the director directly owned 149,794 shares in the company, valued at $3,019,847.04. This trade represents a 57.34% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 11,344,912 shares of company stock worth $228,713,426 in the last 90 days. Company insiders own 63.71% of the company's stock.

Analyst Ratings Changes

A number of brokerages have weighed in on GRDN. Wall Street Zen downgraded shares of Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Truist Financial reissued a "buy" rating and issued a $28.00 price target (up from $25.00) on shares of Guardian Pharmacy Services in a report on Monday, May 19th. Finally, Raymond James Financial set a $28.00 price objective on Guardian Pharmacy Services and gave the stock an "outperform" rating in a report on Wednesday, May 14th.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.